Drugs / Control vaccine younger adults
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06602531 Comparator | Dec 2024 → Jun 2025 | influenza | Arcturus Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Control vaccine younger adults | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06602531 ↗ |
| Modality | Vaccine | “licensed influenza vaccines” NCT06602531 ↗ |
| Route | Intramuscular | “Each participant will receive one intramuscular (IM) dose into the deltoid muscle.” NCT06602531 ↗ |